최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of microbiology and biotechnology, v.15 no.4, 2005년, pp.740 - 744
Lee, Byung-Hee (Department of Food Science and Nutrition, Seoul National University) , Ji, Geun-Eog (Research Center, BIFIDO Co., LTD.)
Bifidobacterium has been previously shown to potentiate immune function, which was mediated through the stimulation of cytokine production by macrophage. This study was performed to further characterize the effective component of Bifidobacterium by measuring the level of interleukin (IL)-6 cytokine ...
Abbas, A. K., A. H. Lichtman, and J. S. Pobe. 1994. Cytokines, p. 240. In Cellular and Molecular Immunology. 2nd Ed. W. B. Saunders Co., Philadelphia, PA
Akira, S., T. Taga, and T. Kishimoto. 1993. Interleukin-6 in biology and medicine. Adv. Immunol. 54: 1-78
Choi, Y J., C. J. Kim, S. Y Park, Y T. Ko, H. K. Jeong, and G E. Ji. 1996. Growth and beta-glucosidase activity of Bifidobacterium. J. Microbiol. Biotechnol. 6: 255-259
Dong, W., J. I. Azcona-Olivera, K. H. Brooks, J. E. Linz, and J. J. Pestka. 1994. Elevated gene expression and production of interleukins 2, 4, 5, and 6 during exposure to vomitoxin (deoxynivalenol) and cycloheximide in the EL-4 thymoma. Toxicol. Appl. Pharmacol. 127: 282-290
Fernandes, C. F. and K. M. Shahani. 1990. Anticarcinogenic and immunological properties of dietary lactobacilli. J. Food Proto 53: 704- 710
Hatcher, G E. and R. S. Lambrecht. 1993. Augmentation of macrophage phagocytic activity by cell-free extracts of selected lactic acid-producing bacteria. J. Dairy Sci. 76: 2485-2492
Hattori, K., A. Yamamoto, M. Sasai, S. Taniuchi, T. Kojima, Y Kobayashi, H. Iwamoto, K. Namba, and T. Yaeshima. 2003. Effects of administration of bifidobacteria on fecal microtlora and clinical symptoms in infants with atopic dermatitis. Arerugi 252: 20-30
Hosono, A, J. Lee, A Ametani, M. Natsume, M. Hirayama, T. Adachi, and S. Kaminogawa. 1997. Characterization of a water-soluble polysaccharide fraction with immunopotentiating activity from Bifidobacterim adolescentis M 101-4. Biosci. Biotech. Biochem. 61: 312-316
Hughes, D. B. and D. G Hoover. 1991. Bifidobacterium: Their potential for use in American dairy products. Food Technol. 45: 74-83
Ishikawa, H., I. Akedo, Y. Umesaki, R. Tanaka, A. lmaoka, and T. Otani. 2003. Randomized controlled trial ofthe effect of Bifidobacterium-fermented milk on ulcerative colitis. J. Am. Call. Nutr. 22: 256-263
Kado-Oka, Y, S. Fujiwara, and T. Hirota. 1991. Effects of Bifidobacterium cells on mitogenic response of splenocytes and several functions of phagocytes. Milchwissenshaft 46: 626-630
Kanauchi, O., K. Mitsuyama, Y Araki, and A. Andoh. 2003. Modification of intestinal flora in the treatment of int1ammatory bowel disease. Curr. Pharm. Res. 9: 336-346
Lammers, K. M., P. Brigidi, B. Vitali, P. Gionchetti, F. Rizzello, E. Caramelli, D. Matteuzzi, and M. Campieri. 2003. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol. Med. Microbiol. 38: 165-172
Lee, J., A. Ametani, A. Enomoto, Y. Sato, H. Motoshima, F. Ike, and S. Kaminogawa. 1993. Screening for the immunopotentiating activity of food microorganisms and enhancement of the immune response by Bifidobacterium adolescentis M101-4. Biosci. Biotech. Biochem. 57: 2127-2132
Miettinen, M., J. Vuopio-Varkila, and K. Varkila. 1996. Production of human necrosis factor alpha, interleukin-6 and interleukin-10 is induced by lactic acid bacteria. Infect. Immun. 64: 5403-5405
Mitsuoka, T. 1982. Recent trends in research on intestinal flora. Bifidobact. Microfl. 1: 3-24
Namioka, S. 1985. Immunoresponsiveness of newborn piglets and peptidoglycan derived from Bifidobacterium. Bifidobact. Microfl. 4: 3-14
Park, S. Y., G. E. Ji, Y. T. Ko, H. K. Jung, Z. Ustunol, and J. J. Pestka. 1999. Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int. J. Food Microbiol. 46: 231-241
Rafter, J. J. 1995. The role of lactic acid bacteria in colon cancer prevention. Scand. J. Gastroenterol. 30: 497-502
Sasaki, T., S. Fukami, and S. Namioka. 1994. Enhanced resistance of mice to Escherichia coli infection induced by administration of peptidoglycan derived from Bifidobacterium thermophilum. J. Vet. Med. Sci. 53: 433-437
Sekine, K., E. Watanabe-Sekine, J. Ohta, T. Toida, T. Tatsuki, T. Kawashima, and Y. Hashimoto. 1994. Induction and activation of tumoricidal cells in vivo and in vitro by the bacterial cell wall of Bifidobacterium infantis. Bifidobact. Microfl. 13: 65-77
Sekine, K., J. Ohta, M. Onishi, T. Tatsuki, Y. Shimokawa, T. Toida, T. Kawashima, and Y. Hashimoto. 1995. Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifidobacterium in/antis. Biol. Pharm. Bull. 18: 148-153
Strober, W. 1991. Trypan blue exclusion test for cell viability, pp. A.3.3-4.ln J. E. Coligan, A. M. Kruisbeek, D. H. Marguiles, E. M. Shevach, and W. Strober (eds.), Current Protocols in Immunology. Greene Pub. and Wiley-Interscience, New York, U.S.A,
Yasui, H. and M. Ohwaki. 1991. Enhancement of immune response in Peyer's patch cells cultured with Bifidobacterium breve. J. Dairy Sci. 74: 1187-1195
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.